Company / Shareholders' Equity
NEPHROS INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$10.2M
FY2025
5-year range
$5.6M / $11.7M
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $667,000 in FY2016 to $13M in FY2020.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -4.0%.
Improved from $9M to $10M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +22.2%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.0%, indicating a declining trend.
- In FY2025, shareholders' equity increased 22.1% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.2M | +22.1% |
| FY2024 | $8.4M | -5.9% |
| FY2023 | $8.9M | +58.8% |
| FY2022 | $5.6M | -52.2% |
| FY2021 | $11.7M | -6.6% |
| FY2020 | $12.5M | +167.9% |
| FY2019 | $4.7M | +23.1% |
| FY2018 | $3.8M | +94.8% |
| FY2017 | $1.9M | +192.4% |
| FY2016 | $667.0K | +125.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026